The global candidiasis drugs market is expected to post a CAGR close to 4% during the period 2019-2023, according to the latest market research report by Technavio.
The signs and symptoms of candidiasis are very broad, and they also depend on the type of candidiasis infection. Therefore, to create awareness about the disease and treatment options and avoid delay in diagnosis, the CDC is providing information about candidiasis, and its causes, risk factors, transmission, diagnosis, and treatment. Furthermore, several organizations are providing free access to online health information to prevent various diseases and minimize the effects of ongoing health conditions, including candidiasis, Hence, the increase in the number of organizations and institutes that create awareness about candidiasis among people is expected to drive the growth of the global candidiasis drugs market during the forecast period.
As per Technavio, the advances in the diagnosis of antifungal-resistant pathogens will have a positive impact on the market and contribute to its growth significantly over the forecast period. This candidiasis drugs market 2019-2023research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Global candidiasis drugs market: Advances in the diagnosis of antifungal-resistant pathogens
Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs and can cause serious bloodstream infections in hospitalized patients. Hence, advanced technologies where the system uses a technology called matrix-assisted laser desorption/ionization (MALDI-TOF) mass spectrometry, in combination with the reference organism database. In this technique, microorganisms, which are cultured from patient samples are ionized by the laser to produce a spectrum of microorganisms, which are matching with the spectrum of reference microorganism database to identify the microorganisms. Such technologies are expected to improve the diagnosis further in coming years, which support the market growth during the forecast period through the early confirmation of the disease for the treatment.
“Apart from the advances in the diagnosis of anti-fungal-resistant pathogens, the provision of special regulatory designations, the high-risk factors of candidiasis and strategic alliances are some other major factors boosting the growth of the global market,” says a senior analyst at Technavio.
Global candidiasis drugs market: Segmentation analysis
This market research report segments the global candidiasis drugs market by type (azoles, echinocandins, other drugs) and geographical regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by North America, APAC, South America, and MEA respectively. However, during the forecast period, the APAC region is expected to register the highest incremental growth due to the rising awareness about diagnosis and management of invasive fungal infections.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
• Market ecosystem
• Market characteristics
• Market segmentation analysis
Market Sizing
• Market definition
• Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
• Regional comparison
• Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at [email protected].

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com